Skip to content
10-Q

Quarterly Report

Amgen Inc. AMGN

0000318154-26-000057

← back to feed
Filed
May 1, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 27, 2026 539.71M sh
Shares Diluted Q1 2026 · Mar 31, 2026 544M sh
Shares Diluted Q1 2026 · Mar 31, 2025 541M sh
Dividends Paid Q1 2026 · Mar 31, 2026 $1.36B
Dividends Paid Q1 2026 · Mar 31, 2025 $1.28B
Capex Q1 2026 · Mar 31, 2026 $712M
Capex Q1 2026 · Mar 31, 2025 $411M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $2.19B
Operating Cash Flow Q1 2026 · Mar 31, 2025 $1.39B
Long Term Debt Q1 2026 · Mar 31, 2026 $51.89B
Long Term Debt Q1 2026 · Dec 31, 2025 $50.01B
Cash And Equivalents Q1 2026 · Mar 31, 2026 $12.04B
Cash And Equivalents Q1 2026 · Dec 31, 2025 $9.13B
Stockholders Equity Q1 2026 · Mar 31, 2026 $9.19B
Stockholders Equity Q1 2026 · Dec 31, 2025 $8.66B
Stockholders Equity Q1 2026 · Mar 31, 2025 $6.21B
Stockholders Equity Q1 2026 · Dec 31, 2024 $5.88B
Current Liabilities Q1 2026 · Mar 31, 2026 $24.96B
Current Liabilities Q1 2026 · Dec 31, 2025 $25.49B
Current Assets Q1 2026 · Mar 31, 2026 $31.48B
Current Assets Q1 2026 · Dec 31, 2025 $29.06B
Total Assets Q1 2026 · Mar 31, 2026 $92.5B
Total Assets Q1 2026 · Dec 31, 2025 $90.59B
Eps Diluted Q1 2026 · Mar 31, 2026 $3.34
Eps Diluted Q1 2026 · Mar 31, 2025 $3.20
Eps Basic Q1 2026 · Mar 31, 2026 $3.37
Eps Basic Q1 2026 · Mar 31, 2025 $3.22
Sga Expense Q1 2026 · Mar 31, 2026 $1.6B
Sga Expense Q1 2026 · Mar 31, 2025 $1.69B
Net Income Q1 2026 · Mar 31, 2026 $1.82B
Net Income Q1 2026 · Mar 31, 2025 $1.73B
Operating Income Q1 2026 · Mar 31, 2026 $2.67B
Operating Income Q1 2026 · Mar 31, 2025 $1.18B
Cost Of Revenue Q1 2026 · Mar 31, 2026 $2.74B
Cost Of Revenue Q1 2026 · Mar 31, 2025 $2.97B
Revenue Q1 2026 · Mar 31, 2026 $8.62B
Revenue Q1 2026 · Mar 31, 2025 $8.15B